[Corrigendum] Eupatolide inhibits the TGF‑β1‑induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5

• Authors:
  • Ariundavaa Boldbaatar
  • Sunyi Lee
  • Sora Han
  • Ae Lee Jeong
  • Hye In Ka
  • Sumiyasuren Buyanravjikh
  • Jeong Hyung Lee
  • Jong‑Seok Lim
  • Myung Sok Lee
  • Young Yang

• View Affiliations

  
  Affiliations: Graduate School of Biological Science, Sookmyung Women's University, Seoul 04310, Republic of Korea, Research Center for Women's Disease, Department of Biological Science, Sookmyung Women's University, Seoul 04310, Republic of Korea, Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea, Department of Biological Science, Sookmyung Women's University, Seoul 04310, Republic of Korea
• Published online on: April 4, 2018     https://doi.org/10.3892/ol.2018.8427
• Pages: 8885-8885

• Copyright : © Boldbaatar et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Oncol Lett 14: [Related article:] 6031-6039, 2017; DOI: 10.3892/ol.2017.6957

We have recently noticed an error in Fig. 2, which appeared in the above-mentioned article. Essentially, the y-axes of the plots showing the relative wound closure were printed inaccurately. The corrected version of Fig. 2 is shown below.

Figure 2. Eupatolide inhibits the migration and invasion of breast cancer cells. (A) MDA-MB-231 and (B) MCF-7 cells were co-treated with either 100 ng/ml EGF or 50 ng/ml TGF-β1, as well as 10 μM eupatolide or a control, and the migration of cells was monitored for 24 h using an IncuCyte live-cell imaging system. After 24 h, relative wound density was acquired by IncuCyte. (C and D) MDA-MB-231 cells were seeded into Transwell chambers and stimulated with (C) 100 ng/ml EGF or (D) 50 ng/ml TGF-β1 independently, or were co-treated with 10 μM eupatolide. The number of invaded cells in the bottom chamber was counted to measure invasion levels. *P<0.05, **P<0.01. EGF, epidermal growth factor; TGF-β1, transforming growth factor-β1; EuTL, eupatolide.

We regret that this error occurred, and thank the Editor for allowing us the opportunity to publish this Corrigendum.